Boston Children’s Hospital:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Boston Children's Hospital - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C0501
◆発行会社(調査会社):GlobalData
◆発行日:2018年7月
◆ページ数:59
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Boston Children’s Hospital (Boston Children’s) is the pediatric medical center that provides a comprehensive range of health care services for children from birth through 21 years of age. Boston Children’s is the primary pediatric teaching affiliate of Harvard Medical School. The organization provides specialty services such as cardiovascular surgery, digestive care, blood diseases, fetal care and others. Its Advanced Fetal Care Center supports the needs of families and referring physicians at all steps of care for various congenital anomalies, from diagnosis and counseling through treatment and follow-up. It also collaborates with other institutes such as Harvard Stem Cell Institute, MIT Health Sciences & Technology, the Broad Institute, the Autism Consortium and Boston University. Boston Children’s is headquartered in Boston, Massachusetts, the US.

Boston Children’s Hospital – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
Boston Children’s Hospital, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
Boston Children’s Hospital, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7
Boston Children’s Hospital, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
Boston Children’s Hospital, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9
Boston Children’s Hospital, Medical Devices Deals, 2012 to YTD 2018 10
Boston Children’s Hospital, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 11
Boston Children’s Hospital, Pharmaceuticals & Healthcare, Deal Details 13
Partnerships 13
ClearPath Vaccines and Astellas Pharma Enter into Research Agreement with Boston Children’s Hospital 13
Amgen Enters into Research Agreement with Boston Children’s Hospital 14
Boston Children’s Hospital Enters into Agreement with GE Healthcare 15
Orchard Therapeutics Enters into Co-Development Agreement for Transformative Gene Therapies 16
Gruenenthal, Proteus and Boston Children’s Hospital Enter into Agreement 17
Grunenthal Enters into Agreement with Proteus and Boston Children’s Hospital 18
Fate Therapeutics Enters into Research Agreement with Boston Children’s Hospital 19
Boston Children’s Hospital Enters Into Co-Development Agreement With Abwiz Bio 20
Shire Enters Into Co-Development Agreement With Boston Children’s Hospital For Pediatric Therapies 21
Life Technologies Enters Into Co-Development Agreement With Boston Children’s Hospital 22
Merger 23
Warren Hospital Merges With St. Luke’s Hospital 23
Licensing Agreements 24
Cambridge Epigenetix Enters into Licensing Agreement with Boston Children’s Hospital 24
Affinivax Enters into Licensing Agreement with Boston Children’s Hospital for MAPS Technology 25
Scholar Rock Enters into Licensing Agreement with Boston Children’s Hospital 26
Boston Children’s Hospital – Key Competitors 27
Boston Children’s Hospital – Key Employees 28
Boston Children’s Hospital – Locations And Subsidiaries 33
Head Office 33
Other Locations & Subsidiaries 33
Joint Venture 34
Recent Developments 35
Strategy And Business Planning 35
May 01, 2017: Boston Orthotics & Prosthetics Adds a Second Clinic in Waltham, MA 35
Government and Public Interest 36
May 11, 2018: Trial shows chemotherapy is helping kids live with pulmonary vein stenosis 36
Apr 04, 2018: A new tactic for antibiotic-resistant pneumonia: Making neutrophils stronger, but fewer in number 38
Apr 02, 2018: Two-drug approach halts lung tumors by starving them metabolically 39
Jan 25, 2018: Cancer researchers hit a bullseye with a new drug target for Ewing sarcoma 41
Jan 10, 2018: Robotic implants spur tissue regeneration inside the body 43
Dec 06, 2017: Routing gene therapy directly into the brain 44
Nov 07, 2017: Boston Children’s Hospital Receives Grant to Support Malaria Research and Music Therapy Program Honoring Dr. Gary Loveman 46
Aug 14, 2017: Breakthrough Study By Pancreatic Cancer Action Network Grantee Evaluates Tumor Growth In Obese Vs. Lean Mice 47
Jul 06, 2017: NIH and Collaborators Identify the Genomic Cause for Carey-Fineman-Ziter Syndrome 48
May 12, 2017: Researchers find key molecule that could lead to new therapies for anemia 50
Mar 20, 2017: New Research Identifies Novel Target for Controlling Immune Response to Implanted Materials 52
Product News 53
Jul 17, 2018: Skewed T-cell pathway may help explain transplant rejection, autoimmune diseases 53
Jan 31, 2018: Sickle cell gene therapy to boost fetal hemoglobin: A 70-year timeline of discovery 56
Other Significant Developments 57
Jan 15, 2018: Multidisciplinary care to treat severe asthma 57
Dec 13, 2017: Care.com and AARP Announce the Launch of the Care Institute to Support the Nation’s Care Workforce and Meet the Rising Demand for Care 58
Appendix 59
Methodology 59
About GlobalData 59
Contact Us 59
Disclaimer 59

List of Tables
Boston Children's Hospital, Pharmaceuticals & Healthcare, Key Facts 2
Boston Children's Hospital, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
Boston Children's Hospital, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7
Boston Children's Hospital, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
Boston Children's Hospital, Deals By Therapy Area, 2012 to YTD 2018 9
Boston Children's Hospital, Medical Devices Deals, 2012 to YTD 2018 10
Boston Children's Hospital, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 11
ClearPath Vaccines and Astellas Pharma Enter into Research Agreement with Boston Children's Hospital 13
Amgen Enters into Research Agreement with Boston Children's Hospital 14
Boston Children's Hospital Enters into Agreement with GE Healthcare 15
Orchard Therapeutics Enters into Co-Development Agreement for Transformative Gene Therapies 16
Gruenenthal, Proteus and Boston Children's Hospital Enter into Agreement 17
Grunenthal Enters into Agreement with Proteus and Boston Children's Hospital 18
Fate Therapeutics Enters into Research Agreement with Boston Children's Hospital 19
Boston Children's Hospital Enters Into Co-Development Agreement With Abwiz Bio 20
Shire Enters Into Co-Development Agreement With Boston Children's Hospital For Pediatric Therapies 21
Life Technologies Enters Into Co-Development Agreement With Boston Children's Hospital 22
Warren Hospital Merges With St. Luke's Hospital 23
Cambridge Epigenetix Enters into Licensing Agreement with Boston Children’s Hospital 24
Affinivax Enters into Licensing Agreement with Boston Children’s Hospital for MAPS Technology 25
Scholar Rock Enters into Licensing Agreement with Boston Children's Hospital 26
Boston Children's Hospital, Key Competitors 27
Boston Children's Hospital, Key Employees 28
Boston Children's Hospital, Key Employees (cont..) 31
Boston Children's Hospital, Other Locations 33
Boston Children's Hospital, Subsidiaries 33
Boston Children's Hospital, Joint Venture 34

List of Figures
Boston Children's Hospital, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Boston Children's Hospital, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Boston Children's Hospital, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Boston Children's Hospital, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Boston Children's Hospital, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
Boston Children's Hospital, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 7
Boston Children's Hospital, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
Boston Children's Hospital, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9
Boston Children's Hospital, Medical Devices Deals, 2012 to YTD 2018 10

★海外企業調査レポート[Boston Children’s Hospital:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • C-Rad AB (CRAD B):医療機器:M&Aディール及び事業提携情報
    Summary C-Rad AB (C-Rad) is a medical device company that develops, manufactures and markets advanced radiation therapy equipments. The company offers products and solutions for patient positioning, tumor localization, and radiation treatment systems. Its products include sentinel 4DCT, catalyst HD, …
  • Genting Plantations Berhad (GENP):企業の財務・戦略的SWOT分析
    Genting Plantations Berhad (GENP) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and we …
  • Maanshan Iron & Steel Company Limited:企業の戦略・SWOT・財務情報
    Maanshan Iron & Steel Company Limited - Strategy, SWOT and Corporate Finance Report Summary Maanshan Iron & Steel Company Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analy …
  • NeuroMetrix Inc (NURO)-医療機器分野:企業M&A・提携分析
    Summary NeuroMetrix Inc (NeuroMetrix) is a medical device company that develops wearable medical technology and point of care test to manage chronic pain, nerve diseases, and sleep disorders. The company’s products include quell wearable pain relief device, SENSUS pain therapy device, NC-stat DPNChe …
  • eLong, Inc.:企業の戦略・SWOT・財務情報
    eLong, Inc. - Strategy, SWOT and Corporate Finance Report Summary eLong, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate act …
  • Bio Techne Corp (TECH):医療機器:M&Aディール及び事業提携情報
    Summary Bio Techne Corp (Bio Techne), formerly Techne, develops, produces, and markets biotechnology products and scientific tools to understand biological processes and drive research. The company’s portfolio encompasses native and recombinant proteins, monoclonal and polyclonal antibodies, immunoa …
  • Clevexel Pharma SAS-製薬・医療分野:企業M&A・提携分析
    Summary Clevexel Pharma SAS (Clevexel) is a drug development company that develops drugs to treat diseases of the central nervous system. The company’s pipeline product portfolio includes CVXL-0107, a glutamate release inhibitor developed to improve the quality of life for Parkinson’s disease patien …
  • Pt Panorama Sentrawisata Tbk:企業の戦略・SWOT・財務分析
    Pt Panorama Sentrawisata Tbk - Strategy, SWOT and Corporate Finance Report Summary Pt Panorama Sentrawisata Tbk - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • University of Arizona-製薬・医療分野:企業M&A・提携分析
    Summary University of Arizona (UA) is a healthcare research university that offers undergraduate and graduate degrees. The university’s academic departments include cancer biology graduate interdisciplinary program, cancer biology, cellular and molecular medicine, cancer center, center for education …
  • GtreeBNT Co Ltd (115450):製薬・医療:M&Aディール及び事業提携情報
    Summary GtreeBNT Co Ltd (GtreeBNT), formerly Digital Aria, is a pharmaceutical company. The company researches and develops pharmaceutical products. It develops GBT-201 for the treatment of ophthalmologic diseases such as dry eye syndrome and neurotrophic keratopathy; and GBT-101 for treating epider …
  • GCL-Poly Energy Holdings Ltd (3800)-エネルギー分野:企業M&A・提携分析
    Summary GCL-Poly Energy Holdings Ltd. (GCL) is a provider of solar photovoltaic (PV) material and professional PV system solutions. The company produces and supplies high-quality solar grade and semiconductor grade polysilicon raw materials and silicon wafers to companies operating in the solar indu …
  • Metabolomic Technologies Inc-医療機器分野:企業M&A・提携分析
    Summary Metabolomic Technologies Inc (MTI) is a biotechnology company that develops metabolomic-based diagnostic systems. The company's products comprise ColoDx, PolypDx, BreastDx, ProstateDx, CeliacDx, ColitisDx, CrohnsDx and other products. Its products develop advanced diagnostic tests for gastro …
  • AdvantEdge Healthcare Solutions Inc:医療機器:M&Aディール及び事業提携情報
    Summary AdvantEdge Healthcare Solutions Inc (AdvantEdge) is a healthcare service provider that offers medical billing, coding and revenue cycle management solutions. The center’s solutions include medical billing, coding, reporting, dashboards and business intelligence, consulting and practice manag …
  • Stifel Financial Corp.:企業のM&A・事業提携・投資動向
    Stifel Financial Corp. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Stifel Financial Corp. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions …
  • Petroleos Mexicanos:石油・ガス:M&Aディール及び事業提携情報
    Summary Petroleos Mexicanos (PEMEX) is a state-owned integrated oil and gas company. It operates across the value chain of oil and gas industry, from exploration and production to processing, logistics and marketing. PEMEX also produces and distributes a wide range of petrochemical products. The com …
  • VGP N.V.:企業の戦略・SWOT・財務情報
    VGP N.V. - Strategy, SWOT and Corporate Finance Report Summary VGP N.V. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, …
  • Titan Petrochemicals Group Limited (1192):石油・ガス:M&Aディール及び事業提携情報
    Summary Titan Petrochemicals Group Limited (Titan) is an investment holding company that carries out midstream energy and shipbuilding operations. It provides oil storage, transit, and blending services. The company transports oil and petrochemical products; and supplies oil products. Titan also car …
  • Photronics Inc (PLAB):企業の財務・戦略的SWOT分析
    Summary Photronics Inc (Photronics) is a manufacturer of semiconductor photomasks. The company’s products include mature binary, advanced binary reticles, embedded attenuated phase shift masks, large area masks for flat panel displays, high transmission embedded attenuated phase shift masks, alterna …
  • Icagen Inc:企業の戦略的SWOT分析
    Icagen Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. T …
  • SRP Groupe SA (SRP):企業の財務・戦略的SWOT分析
    SRP Groupe SA (SRP) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and t …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆